117 related articles for article (PubMed ID: 35192293)
1. Evaluation of Pathologic Prognostic Factors in Neuroendocrine Tumors of the Small Intestine.
Polydorides AD; Liu Q
Am J Surg Pathol; 2022 Apr; 46(4):547-556. PubMed ID: 35192293
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors.
Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK
JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112
[TBL] [Abstract][Full Text] [Related]
3. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis.
Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C
Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993
[TBL] [Abstract][Full Text] [Related]
4. The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors.
Wu L; Chen F; Chen S; Wang L
Neuroendocrinology; 2018; 107(3):209-217. PubMed ID: 29920478
[TBL] [Abstract][Full Text] [Related]
5. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors.
Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP
J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726
[TBL] [Abstract][Full Text] [Related]
6. Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors.
Gonzalez RS; Cates JMM; Shi C
Mod Pathol; 2018 Oct; 31(10):1560-1566. PubMed ID: 29795438
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors.
Jiang S; Zhao L; Xie C; Su H; Yan Y
Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379
[No Abstract] [Full Text] [Related]
8. Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?
Gonzalez RS; Liu EH; Alvarez JR; Ayers GD; Washington MK; Shi C
Mod Pathol; 2014 Sep; 27(9):1288-95. PubMed ID: 24457461
[TBL] [Abstract][Full Text] [Related]
9. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
[TBL] [Abstract][Full Text] [Related]
10. Peritoneal Metastases from Gastroenteropancreatic Neuroendocrine Tumors: Incidence, Risk Factors and Prognosis.
Madani A; Thomassen I; van Gestel YRBM; van der Bilt JDW; Haak HR; de Hingh IHJT; Lemmens VEPP
Ann Surg Oncol; 2017 Aug; 24(8):2199-2205. PubMed ID: 28204963
[TBL] [Abstract][Full Text] [Related]
11. Relevant prognostic factors in patients with stage IV small intestine neuroendocrine neoplasms.
Maurer E; Heinzel-Gutenbrunner M; Rinke A; Rütz J; Holzer K; Figiel J; Luster M; Bartsch DK
J Neuroendocrinol; 2022 Jan; 34(1):e13076. PubMed ID: 34964186
[TBL] [Abstract][Full Text] [Related]
12. Surgical Management of Small Bowel Neuroendocrine Tumors: Specific Requirements and Their Impact on Staging and Prognosis.
Pasquer A; Walter T; Hervieu V; Forestier J; Scoazec JY; Lombard-Bohas C; Poncet G
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S742-9. PubMed ID: 26014153
[TBL] [Abstract][Full Text] [Related]
13. Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties.
Kankava K; Maisonneuve P; Mangogna A; Centonze G; Cattaneo L; Prinzi N; Pusceddu S; Fazio N; Pisa E; Di Domenico S; Bertani E; Mazzaferro V; Albertelli M; Grillo F; Milione M
J Neuroendocrinol; 2021 Aug; 33(8):e13000. PubMed ID: 34268808
[TBL] [Abstract][Full Text] [Related]
14. Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors.
Martin JA; Warner RRP; Aronson A; Wisnivesky JP; Kim MK
Pancreas; 2017 Oct; 46(9):1214-1218. PubMed ID: 28902794
[TBL] [Abstract][Full Text] [Related]
15. The conundrum of < 2-cm pancreatic neuroendocrine tumors: A preoperative risk score to predict lymph node metastases and guide surgical management.
Lopez-Aguiar AG; Ethun CG; Zaidi MY; Rocha FG; Poultsides GA; Dillhoff M; Fields RC; Idrees K; Cho CS; Abbott DE; Cardona K; Maithel SK
Surgery; 2019 Jul; 166(1):15-21. PubMed ID: 31072670
[TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors Associated With Progression for Advanced-Stage/G1 and G2 Small-Bowel Neuroendocrine Tumors After Multimodal Therapy: Experience From a Tertiary Referral Center.
Khetan P; Oyewole F; Wolin E; Kim MK; Divino CM
Pancreas; 2020 Apr; 49(4):509-513. PubMed ID: 32224719
[TBL] [Abstract][Full Text] [Related]
17. Tumor size as a prognostic factor in patients with advanced gastric cancer in the lower third of the stomach.
Wang HM; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J
World J Gastroenterol; 2012 Oct; 18(38):5470-5. PubMed ID: 23082065
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine.
Liu Q; Polydorides AD
Mod Pathol; 2020 Nov; 33(11):2318-2329. PubMed ID: 32514164
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for progression of appendiceal neuroendocrine tumours: low-stage tumours <5 mm appear to be overwhelmingly indolent and may merit a separate designation.
Noor M; Huber AR; Cates JMM; Gonzalez RS
Histopathology; 2021 Sep; 79(3):416-426. PubMed ID: 33754384
[TBL] [Abstract][Full Text] [Related]
20. Extent of Lymph Node Dissection for Small Bowel Neuroendocrine Tumors.
Hallet J; Law C;
World J Surg; 2021 Jan; 45(1):197-202. PubMed ID: 32737557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
